Cited by 8,029Heart Failure Treatment and ManagementHeart rate and cardiovascular healthCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

Open access

The SOLVD Investigators*·1991·New England Journal of Medicine

DOI 10.1056/nejm199108013250501

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Patients with congestive heart failure have a high mortality rate and are also hospitalized frequently. We studied the effect of an angiotensin-converting-enzyme inhibitor, enalapril, on mortality and hospitalization in patients with chronic heart failure and ejection fractions less than or equal to 0.35. METHODS: Patients receiving conventional treatment for heart failure were randomly assigned to receive either placebo (n = 1284) or enalapril (n = 1285) at doses of 2.5 to 20 mg per day in a double-bind trial. Approximately 90 percent of the patients were in New York Heart Association functional classes II and III. The follow-up averaged 41.4 months. RESULTS: There were 510 deaths in the placebo group (39.7 percent), as compared with 452 in the enalapril group (35.2 percent) (reduction in risk, 16 percent; 95 percent confidence interval, 5 to 26 percent; P = 0.0036). Although reductions in mortality were observed in several categories of cardiac deaths, the largest reduction occurred among the deaths attributed to progressive heart failure (251 in the placebo group vs. 209 in the enalapril group; reduction in risk, 22 percent; 95 percent confidence interval, 6 to 35 percent). There was little apparent effect of treatment on deaths classified as due to arrhythmia without pump failure. Fewer patients died or were hospitalized for worsening heart failure (736 in the placebo group and 613 in the enalapril group; risk reduction, 26 percent; 95 percent confidence interval, 18 to 34 percent; P less than 0.0001). CONCLUSIONS: The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108013250501

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A. N., Devereux, R. B., Feigenbaum, H., Gutgesell, H. P., Reichek, N., Sahn, D. J., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,110
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,109
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
Francis, G. S., Benedict, C. R., Johnstone, D. E., Kirlin, P. C., Nicklas, J. M., Liang, C., Kubo, S. H., Rudin-Toretsky, E., & Yusuf, S. (1990) · Circulation · doi:10.1161/01.cir.82.5.1724 · Cited by 1,386

Show all 15 references

Research works printed but not linked: 1

Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.

Sorted by citations

Items 801–900 of 1,027

Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.11.027 · Cited by 147
Mecánica ventricular izquierda normal mediante ecocardiografía speckle tracking bidimensional. Valores de referencia para adultos sanos
Kocabay, G., Muraru, D., Peluso, D., Cucchini, U., Mihaila, S. B., Jose, S. P., Denas, G., Iliceto, S., Vinereanu, D., & Badano, L. P. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.12.011 · Cited by 146
Therapeutic Targets in Heart Failure
Schelbert, E. B., Fonarow, G. C., Bonow, R. O., Butler, J., & Gheorghiade, M. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.068 · Cited by 146
Comprehensive multidisciplinary programs for the management of patients with congestive heart failure
Philbin, E. F. (1999) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1999.00291.x · Cited by 146
Improvements in 1-Year Cardiovascular Clinical Outcomes Associated with a Hospital-Based Discharge Medication Program
Lappé, J. M., Muhlestein, J. B., LAPPE, D. L., Badger, R. S., Bair, T. L., Brockman, R., French, T. K., Hofmann, L., Horne, B. D., Kralick-Goldberg, S., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-6-200409210-00010 · Cited by 146
Mechanical Circulatory Support and Cardiac Transplantation
Hunt, S. A., & Frazier, O. H. (1998) · Circulation · doi:10.1161/01.cir.97.20.2079 · Cited by 146
Rationale and design of the valsartan heart failure trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure
Cohn, J. N., Tognoni, G., Glazer, R. D., Spormann, D., & Hester, A. (1999) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(99)90038-6 · Cited by 146
Type 2 diabetes mellitus and heart failure, a scientific statement from the American Heart Association and Heart Failure Society of America
Dunlay, S. M., Givertz, M. M., Aguilar, D., Allen, L. A., Chan, M., Desai, A. S., Deswal, A., Dickson, V. V., Kosiborod, M. N., Lekavich, C. L., et al. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.05.007 · Cited by 145
Relation of daily activity levels in patients with chronic heart failure to long-term prognosis
Walsh, J. T., Charlesworth, A., Andrews, R. V., Hawkins, M., & Cowley, A. J. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00141-0 · Cited by 145
Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension
Pepine, C. J., Handberg, E. M., Marks, R. G., Conlon, M., Cooper‐DeHoff, R. M., Volkers, P., & Zellig, P. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00423-9 · Cited by 145
Selective Stimulation of Tissue-Type Plasminogen Activator (t-PA) In Vivo by Infusion of Bradykinin
Brown, N. J., Nadeau, J., & Vaughan, D. E. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656000 · Cited by 145
Clinical Characteristics and Outcome of Hospitalized Patients With Heart Failure in Japan Rationale and Design of Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD)
Tsutsui, H., Tsuchihashi‐Makaya, M., Kinugawa, S., Goto, D., Takeshita, A., & The JCARE-CARD Investigators (2006) · Circulation Journal · doi:10.1253/circj.70.1617 · Cited by 144
Self-citation
Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study
BORER, J. S., Böhm, M., Ford, I., Michel Komajda, N., Tavazzi, L., Sendon, J. L., Alings, M., de Sá, E. L., Swedberg, K. B., & on behalf of the SHIFT Investigators (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs259 · Cited by 144
Insights into the contemporary epidemiology and outpatient management of congestive heart failure
McAlister, F. A., Teo, K. K., Taher, M., Montague, T. J., Humen, D. P., Cheung, L. K., Kiaii, M., Yim, R., & Armstrong, P. W. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70251-6 · Cited by 144
Central Role of the MAPK Pathway in Ang II–Mediated DNA Synthesis and Migration in Rat Vascular Smooth Muscle Cells
Xi, X.-P., Graf, K., Goetze, S., Fleck, E., Hsueh, W. A., & Law, R. E. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.1.73 · Cited by 144
Is the prognosis of heart failure improving?
Khand, A. U., Gemmell, I., Clark, A. L., & Cleland, J. G. F. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00995-5 · Cited by 144
The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure
Sin, D. D., & McAlister, F. A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01346-3 · Cited by 143
A double-blind, placebo-controlled, dose–response study of the effectiveness and safety of lisinopril for children with hypertension
Soffer, B. A. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)00900-2 · Cited by 143
1-Adrenergic receptors prevent a maladaptive cardiac response to pressure overload
O’Connell, T. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci22811 · Cited by 143
Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony
Fruhwald, F. M., Fahrleitner‐Pammer, A., Berger, R., Leyva, F., Freemantle, N., Erdmann, E., Gras, D., Kappenberger, L., Tavazzi, L., Daubert, J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl505 · Cited by 142
Retrospective analysis of thecost-effectiveness of using plasmabrain natriuretic peptide inscreening for left ventricularsystolic dysfunction in the general population
Nielsen, O. W., McDonagh, T. A., Robb, S., & Dargie, H. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02625-6 · Cited by 142
Palliative Care for Patients With Heart Failure
Pantilat, S. Z. (2004) · JAMA · doi:10.1001/jama.291.20.2476 · Cited by 142
Successes and failures of current treatment of heart failure
Cleland, J. G., Swedberg, K., & Poole-Wilson, P. A. (1998) · The Lancet · doi:10.1016/s0140-6736(98)90015-0 · Cited by 141
The STICH Trial (Surgical Treatment for Ischemic Heart Failure)
Carson, P. E., WERTHEIMER, J. H., Miller, A. B., O’Connor, C. M., Piña, I. L., Selzman, C. H., Sueta, C. A., She, L., Greene, D., Lee, K. L., et al. (2013) · JACC Heart Failure · doi:10.1016/j.jchf.2013.04.012 · Cited by 141
Mast cell chymase limits the cardiac efficacy of Ang I–converting enzyme inhibitor therapy in rodents
Wei, C., Hase, N., Inoue, Y., Bradley, E. W., Yahiro, E., Li, M., Naqvi, N., Powell, P. C., Shi, K., Takahashi, Y., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39345 · Cited by 141
Renin Inhibition in Hypertension
Gradman, A. H., & Kad, R. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.027 · Cited by 141
Effects of Dihydrocodeine on Chemosensitivity and Exercise Tolerance in Patients With Chronic Heart Failure
Chua, T. P., Harrington, D., Ponikowski, P. P., Webb-Peploe, K., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00446-9 · Cited by 141
How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the disease
Packer, M. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90081-m · Cited by 141
Chymase-dependent angiotensin II forming system in humans
Urata, H. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00349-5 · Cited by 141
Metabolic Rates of ATP Transfer Through Creatine Kinase (CK Flux) Predict Clinical Heart Failure Events and Death
Bottomley, P. A., Panjrath, G. S., Lai, S., Hirsch, G. A., Wu, K. C., Najjar, S. S., Steinberg, A. M., Gerstenblith, G., & Weiss, R. G. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007328 · Cited by 140
Congestive Heart Failure After Surgical Correction of Mitral Regurgitation
Enriquez-Sarano, M. L., Schaff, H. V., Orszulak, T. A., Bailey, K. R., Tajik, A. J., & Frye, R. L. (1995) · Circulation · doi:10.1161/01.cir.92.9.2496 · Cited by 140
2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation
Roffi, M., Patrono, C., Collet, J., Mueller, C. E., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2015) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2015.10.009 · Cited by 139
Diabetes Mellitus, the Renin-Angiotensin-Aldosterone System, and the Heart
Lim, H. S., MacFadyen, R. J., & Lip, G. Y. H. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.16.1737 · Cited by 139
The origin of sympathetic outflow in heart failure: the roles of angiotensin II and nitric oxide
Zucker, I. H., Schultz, H. D., Li, Y.-F., Wang, Y., Wang, W., & Patel, K. P. (2003) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2003.11.010 · Cited by 139
Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation
Tichelli, A., Bhatia, R., & Socié, G. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07165.x · Cited by 139
Critical Care Nephrology
Kellum, J. A., Bellomo, R., & Ronco, C. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10066-1 · Cited by 139
Controlled Clinical Evaluation of Enalapril in Dogs With Heart Failure: Results of the Cooperative Veterinary Enalapril Study Group The COVE Study Group
Woodfield, J. A. (1995) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.1995.tb01075.x · Cited by 139
Statins and Blockers of the Renin-Angiotensin System
Faggiotto, A., & Paoletti, R. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.987 · Cited by 139
Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction
Wright, R. A., Flapan, A. D., Alberti, K. G. M. M., Ludlam, C. A., & Fox, K. A. A. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90543-6 · Cited by 139
Differences in Tissue Angiotensin II–Forming Pathways by Species and Organs In Vitro
Akasu, M., Urata, H., Kinoshita, A., Sasaguri, M., Ideishi, M., & Arakawa, K. (1998) · Hypertension · doi:10.1161/01.hyp.32.3.514 · Cited by 138
Angiotensin II Stimulates Matrix Metalloproteinase Secretion in Human Vascular Smooth Muscle Cells via Nuclear Factor-κB and Activator Protein 1 in a Redox-Sensitive Manner
Browatzki, M., Larsen, D., Pfeiffer, C. A. H., Gehrke, S. G., Schmidt, J., Kranzhöfer, A., Katus, H. A., & Kranzhöfer, R. (2005) · Journal of Vascular Research · doi:10.1159/000087451 · Cited by 138
High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months
Tremel, F., Pépin, J., Veale, D., Wuyam, B., Siche, J. P., Mallion, J.-M., & Levy, P. A. (1999) · European Heart Journal · doi:10.1053/euhj.1999.1546 · Cited by 138
Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency
Atkins, C. E., Keene, B. W., Brown, W. A., Coats, J. R., Crawford, M. A., DeFrancesco, T. C., Edwards, N. J., Fox, P. R., Lehmkuhl, L. B., Luethy, M. W., et al. (2007) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.231.7.1061 · Cited by 137
Heart Failure in Women
Bozkurt, B., & Khalaf, S. Z. (2017) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-13-4-216 · Cited by 137
Impaired regulation of cardiac function in sepsis, SIRS, and MODSThis article is one of a selection of papers from the NATO Advanced Research Workshop on Translational Knowledge for Heart Health (published in part 2 of a 2-part Special Issue).
Werdan, K., Schmidt, H., Ebelt, H., Zorn‐Pauly, K., Koidl, B., Hoke, R. S., Heinroth, K. M., & Müller‐Werdan, U. (2009) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y09-012 · Cited by 137
Utility of B-Type Natriuretic Peptide (BNP) as a Screen for Left Ventricular Dysfunction in Patients With Diabetes
Epshteyn, V. A., Morrison, K. C., Krishnaswamy, P., Kazanegra, R., Clopton, P., Mudaliar, S. R. D., Edelman, S. V., Henry, R., & Maisel, A. S. (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2081 · Cited by 137
Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype
Cicoira, M., Zanolla, L., Rossi, A., Golia, G., Franceschini, L., Cabrini, G., Bonizzato, A., Graziani, M., Anker, S. D., Coats, A. J. S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01237-2 · Cited by 137
Aldosterone in Chronic Kidney and Cardiac Disease
Hostetter, T. H., & Ibrahim, H. N. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000086472.65806.73 · Cited by 137
Assessing left ventricular systolic function: from ejection fraction to strain analysis
Halliday, B. P., Senior, R., & Pennell, D. J. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa587 · Cited by 136
Angiotensin-Converting Enzyme Inhibitors Downregulate Tissue Factor Synthesis in Monocytes
Napoleone, E., Santo, A. D., Camera, M., Tremoli, E., & Lorenzet, R. (2000) · Circulation Research · doi:10.1161/01.res.86.2.139 · Cited by 136
Aldosterone and Myocardial Fibrosis in Heart Failure
Brilla, C. G. (2000) · Herz · doi:10.1007/s000590050024 · Cited by 135
Treatment of Hypertension in Patients With Coronary Artery Disease
Rosendorff, C., Lackland, D. T., Allison, M., Aronow, W. S., Black, H. R., Blumenthal, R. S., Cannon, C. P., de Lemos, J. A., Elliott, W. J., Findeiss, L., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.038 · Cited by 135
The timing of development and subsequent clinical course of heart failure after a myocardial infarction
Torabi, A., Cleland, J. G. F., Khan, N. K., Loh, P. H., Clark, A. L., Alamgir, F., Caplin, J., Rigby, A. S., & Goode, K. M. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn096 · Cited by 135
Heart failure in beta thalassemia: a 5-year follow-up study
Kremastinos, D. T. H., Tsetsos, G. A., Tsiapras, D. P., Karavolias, G., Ladis, V., & KATTAMIS, C. A. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00879-8 · Cited by 135
Cheyne-Stokes Respiration in Stroke
Nopmaneejumruslers, C., Kaneko, Y., Hajek, V. E., Zivanovic, V., & Bradley, T. D. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200411-1591oc · Cited by 135
The Oxidative Stress Hypothesis of Congestive Heart Failure
Mak, S. S., & Newton, G. E. (2001) · CHEST Journal · doi:10.1378/chest.120.6.2035 · Cited by 135
Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition
van de Wal, R. M. A., Plokker, H. W. M., Lok, D. J. A., Boomsma, F., van der Horst, F. A. L., van Veldhuisen, D. J., van Gilst, W. H., & Voors, A. A. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.02.016 · Cited by 135
Diastolic dysfunction as a cause of heart failure
Litwin, S. E., & Grossman, W. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90463-b · Cited by 134
Targeting Fibrosis for the Treatment of Heart Failure: A Role for Transforming Growth Factor‐β
Edgley, A. J., Krum, H., & Kelly, D. J. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00228.x · Cited by 134
Physiology and clinical implications of variability of cardiovascular parameters with focus on heart rate and blood pressure
Malliani, A., Pagani, M., & Lombardi, F. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90617-3 · Cited by 134
Risk Assessment for Incident Heart Failure in Individuals With Atrial Fibrillation
Schnabel, R. B., Rienstra, M., SULLIVAN, L. M., Sun, F. X., Moser, C., Levy, D. A., Pencina, M. J., Fontes, J. D., Magnani, J. W., McManus, D. D., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft041 · Cited by 133
Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure
Turagam, M. K., Garg, J., Whang, W., Sartori, S., Koruth, J. S., Miller, M. A., Langan, N., Sofi, A. A., Gomes, A., Choudry, S., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0992 · Cited by 133
Outcomes of Acute Exacerbation of Severe Congestive Heart Failure Quality of Life, Resource Use, and Survival
Jaagosild, P. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.10.1081 · Cited by 133
Rationale, design, implementation, and baseline characteristics of patients in the dig trial: A large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure
The Digitalis Investigation Group (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00065-8 · Cited by 133
The Impact of Changing Medical Therapy on Transplantation-Free Survival in Pediatric Dilated Cardiomyopathy
Kantor, P. F., Abraham, J. R., Dipchand, A. I., Benson, L. N., & Redington, A. N. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.059 · Cited by 132
Direct Cardiac Reprogramming
Sadahiro, T., Yamanaka, S., & Ieda, M. (2015) · Circulation Research · doi:10.1161/circresaha.116.305374 · Cited by 132
Pathophysiologic and Therapeutic Importance of Tissue ACE: A Consensus Report
Dzau, V. J., Bernstein, K. E., Celermajer, D. S., Cohen, J. D., Dahlöf, B., Deanfield, J. E., Díez, J., Drexler, H., Ferrari, R., van Gilst, W. H., et al. (2002) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1015709617405 · Cited by 132
A multicenter disease management program for hospitalized patients with heart failure
Tsuyuki, R. T., Fradette, M., Johnson, J. A., Bungard, T. J., Eurich, D. T., Ashton, T., Gordon, W., Ikuta, R. M., Kornder, J. M., Mackay, E., et al. (2004) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2004.02.005 · Cited by 132
The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure.
Fuat, A., Murphy, J. J., Hungin, A. P. S., Curry, J., Mehrzad, A., Hetherington, A., Johnston, J. I., Smellie, W. S. A., Duffy, V., & Cawley, P. (2006) · Europe PMC (PubMed Central) · Cited by 132
Anthracycline cardiotoxicity
Jones, R. L., Swanton, C., & Ewer, M. S. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.6.791 · Cited by 132
Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): Design and rationale
Shah, M. R., O’Connor, C. M., Sopko, G. S., Hasselblad, V., Califf, R. M., & Stevenson, L. W. (2001) · American Heart Journal · doi:10.1067/mhj.2001.113995 · Cited by 132
Subgroup analyses in therapeutic cardiovascular clinical trials: Are most of them misleading?
Hernández, A. V., Boersma, E., Murray, G. D., Habbema, J. D. F., & Steyerberg, E. W. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.020 · Cited by 131
Renin–Angiotensin Blockade Combined With Natriuretic Peptide System Augmentation
von Lueder, T. G., Sangaralingham, S. J., Wang, B. H., Kompa, A. R., Atar, D., Burnett, J. C. J., & Krum, H. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.000289 · Cited by 131
MECHANISMS OF SYMPATHETIC ACTIVATION IN HEART FAILURE
Watson, A., Hood, S., & May, C. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04523.x · Cited by 131
Circulating ACE2 activity correlates with cardiovascular disease development
Katalin, Ú., Fagyas, M., Kertész, A., Borbély, A., Jenei, C., Bene, O., Csanádi, Z., Paulus, W. J., Edes, I. F., Papp, Z., et al. (2016) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320316668435 · Cited by 131
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction
Martin, N., Manoharan, K., Thomas, J., Davies, C., & Lumbers, R. T. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012721.pub2 · Cited by 131
Chronic Heart Failure
Morrissey, R. P., Czer, L. S. C., & Shah, P. K. (2011) · American Journal of Cardiovascular Drugs · doi:10.2165/11592090-000000000-00000 · Cited by 131
Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy
Ogata, H., Ishikawa, Y., Ishikawa, Y., & Minami, R. (2008) · Journal of Cardiology · doi:10.1016/j.jjcc.2008.08.013 · Cited by 131
The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy
Daly, C., Fox, K. M., Remme, W. J., Bertrand, M. E., Ferrari, R., & Simoons, M. L. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi225 · Cited by 131
TRV120027, a Novel β-Arrestin Biased Ligand at the Angiotensin II Type I Receptor, Unloads the Heart and Maintains Renal Function When Added to Furosemide in Experimental Heart Failure
Boerrigter, G., Soergel, D. G., Violin, J. D., Lark, M. W., & Burnett, J. C. J. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.969220 · Cited by 130
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes
Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., & Stevenson, W. G. (2006) · Circulation · doi:10.1161/circulationaha.106.655761 · Cited by 130
Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls
Grain, L., Cortina‐Borja, M., Forfar, C., Hilton‐Jones, D., Hopkin, J. M., & Burch, M. (2001) · Neuromuscular Disorders · doi:10.1016/s0960-8966(00)00185-1 · Cited by 130
Practical Recommendations for the Use of ACE Inhibitors, Beta-Blockers, Aldosterone Antagonists and Angiotensin Receptor Blockers in Heart Failure: Putting Guidelines into Practice
McMurray, J. J. V., Solal, A. C., Dietz, R., Eichhorn, E. J., Erhardt, L., Hobbs, R. F., Krum, H., Maggioni, A. P., McKelvie, R. S., Piña, I. L., et al. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.07.002 · Cited by 130
Role of apoptosis in remodeling after myocardial infarction
Takemura, G., & Fujiwara, H. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.07.005 · Cited by 130
Sudden Cardiac Death in Heart Failure
Marbán, E., & Tomaselli, G. F. (1998) · Medical science symposia series · doi:10.1007/978-94-011-5022-4_40 · Cited by 130
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations
Klein, L., O’Connor, C. M., Gattis, W. A., Zampino, M., Luca, L. D., Vitarelli, A., Fedele, F., & Gheorghiade, M. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03336-2 · Cited by 130
The Verdict From ALLHAT—Thiazide Diuretics Are the Preferred Initial Therapy for Hypertension
Appel, L. J. (2002) · JAMA · doi:10.1001/jama.288.23.3039 · Cited by 130
Is the Gap Between Guidelines and Clinical Practice in Heart Failure Treatment Being Filled? Insights from the IMPACT RECO Survey
de Groote, P., Isnard, R., Assyag, P., Clerson, P., Ducardonnet, A., Galinier, M., Jondeau, G., Leurs, I., Thébaut, J.-F., & Michel Komajda, N. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.09.008 · Cited by 129
Direct Renin Inhibition in Addition to or as an Alternative to Angiotensin Converting Enzyme Inhibition in Patients with Chronic Systolic Heart Failure: Rationale and Design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) Study
Krum, H., Massie, B. M., Abraham, W. T., Dickstein, K., Køber, L., McMurray, J. J. V., Desai, A., Gimpelewicz, C. R., Kandra, A., Reimund, B., et al. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq212 · Cited by 129
Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapy
Sato, A. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)00913-0 · Cited by 129
Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease
Petrie, M. C., Padmanabhan, N., McDonald, J. E., Hillier, C., Connell, J., & McMurray, J. J. V. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01111-1 · Cited by 129
Intracoronary Adenovirus-Mediated Delivery and Overexpression of the β 2 -Adrenergic Receptor in the Heart
Shah, A. S., Lilly, R. E., Kypson, A. P., Tai, O., Hata, J. A., Pippen, A. M., Silvestry, S., Lefkowitz, R. J., Glower, D. D., & Koch, W. J. (2000) · Circulation · doi:10.1161/01.cir.101.4.408 · Cited by 129
Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives
Kjær, A., & Hesse, B. (2001) · Clinical Physiology · doi:10.1046/j.1365-2281.2001.00371.x · Cited by 129
Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators.
Cowley, A., & Skene, A. M. (1994) · Heart · doi:10.1136/hrt.72.3.226 · Cited by 129
Who benefits from medical interventions?
Smith, G. D., & Egger, M. (1994) · BMJ · doi:10.1136/bmj.308.6921.72 · Cited by 128
β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury
Kim, K.-S., Abraham, D., Williams, B. Y., Violin, J. D., Mao, L., & Rockman, H. A. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00475.2012 · Cited by 128
ACE-inhibitor use and the long-term risk of renal failure in diabetes
Suissa, S., Hutchinson, T., Brophy, J. M., & Kezouh, A. (2006) · Kidney International · doi:10.1038/sj.ki.5000159 · Cited by 128
Vascular and cardiac benefits of angiotensin receptor blockers
Schiffrin, E. L. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01241-x · Cited by 128
The Clinical Implications of Aldosterone Escape in Congestive Heart Failure
Struthers, A. D. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.04.013 · Cited by 128
Congenital heart disease: the original heart failure syndrome
Bolger, A. P. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00005-8 · Cited by 128

Authors: The SOLVD Investigators*
Corresponding author: The SOLVD Investigators*
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08
Volume: 325
Issue: 5
Pages: 293-302
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108013250501
OpenAlex: W2585382523
Cited by: 8,029
References: 15
Citations by year: 2026: 78 · 2025: 89 · 2024: 117 · 2023: 152 · 2022: 174 · 2021: 167 · 2020: 182 · 2019: 174 · 2018: 174 · 2017: 187 · 2016: 211 · 2015: 208 · 2014: 165 · 2013: 168 · 2012: 231
FWCI: 170.62
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: enalapril, ACE inhibitors, congestive heart failure, reduced left ventricular ejection fraction, mortality, hospitalization, heart failure progression, cardiac arrhythmias, NYHA functional class
MeSH terms: Blood Pressure, Cause of Death, Chronic Disease, Double-Blind Method, Electrolytes, Enalapril, Female, Follow-Up Studies, Heart Failure, Hospitalization, Humans, Kidney, Male, Middle Aged, Patient Compliance, Stroke Volume, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks